Log In
Print this Print this

Short hairpin RNA against TUBB3, shRNAi for drug resistant lung cancer

  Manage Alerts
Collapse Summary General Information
Company Benitec Biopharma Ltd.
DescriptionShort hairpin RNA (shRNA) that inhibits tubulin beta 3 (TUBB3)
Molecular Target Tubulin beta 3 (TUBB3)
Mechanism of Action 
Therapeutic ModalityNucleic acid: Linear RNA: shRNA
Latest Stage of DevelopmentPreclinical
Standard IndicationNon-small cell lung cancer (NSCLC)
Indication DetailsTreat drug resistant non-small cell lung cancer (NSCLC)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today